GLADSTONE COMMERCIAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GLADSTONE COMMERCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $161.34M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $149.39M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $147.58M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $148.98M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $137.69M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $133.15M | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | $29.39M | Feb 12, 2020 |
| FY2019 | Sep 30, 2019 | $28.67M | Feb 12, 2020 |
| FY2019 | Jun 30, 2019 | $28.20M | Feb 12, 2020 |
| FY2019 | Mar 31, 2019 | $28.14M | Feb 12, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.29M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $24.00M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $4.99M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $10.81M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $10.94M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $14.94M | Feb 22, 2023 |
| FY2019 | Dec 31, 2019 | $472.0K | Feb 12, 2020 |
| FY2019 | Sep 30, 2019 | $2.19M | Feb 12, 2020 |
| FY2019 | Jun 30, 2019 | $2.21M | Feb 12, 2020 |
| FY2019 | Mar 31, 2019 | $4.67M | Feb 12, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.15M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $56.95M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $60.37M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $69.18M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $70.13M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $65.49M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $60.19M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $55.60M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $46.84M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $41.16M | Feb 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.09B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $1.13B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $1.20B | Feb 21, 2024 |
| FY2023 | Dec 31, 2021 | $1.14B | Feb 21, 2024 |
| FY2021 | Dec 31, 2020 | $1.10B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $1.04B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $938.78M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $928.45M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $851.74M | Feb 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $905.00M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $753.01M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $809.16M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $826.88M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $770.53M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $722.59M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $676.32M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $598.76M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $578.22M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $541.12M | Feb 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $171.77M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $171.17M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $153.28M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $203.90M | Feb 21, 2024 |
| FY2023 | Dec 31, 2021 | $200.92M | Feb 21, 2024 |
| FY2021 | Dec 31, 2020 | $213.18M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $208.13M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $249.74M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $266.80M | Feb 13, 2019 |
| FY2018 | Dec 31, 2016 | $239.88M | Feb 13, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.81M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $10.96M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $11.99M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $11.65M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $7.96M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $11.02M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $6.85M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $6.59M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $6.68M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $4.66M | Feb 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $843.47M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $693.39M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $738.86M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $749.21M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $707.53M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $669.28M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $626.59M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $566.06M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $542.63M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $509.40M | Feb 14, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 13, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 13, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 48.41M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 43.99M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | 40.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | 39.74M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 37.47M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 35.33M | Feb 15, 2022 |
| FY2025 | Feb 20, 2020 | 60.29M | Feb 18, 2026 |
| FY2025 | Feb 19, 2020 | 86.29M | Feb 18, 2026 |
| FY2020 | Dec 31, 2019 | 32.59M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | 29.25M | Feb 12, 2020 |